Wells Fargo analyst Mohit Bansal reiterated an Overweight rating and $860.00 price target on Regeneron Pharma (NASDAQ: REGN)."We ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE